Skip to main content
. Author manuscript; available in PMC: 2013 Dec 1.
Published in final edited form as: Neuropharmacology. 2012 Aug 5;63(7):1238–1247. doi: 10.1016/j.neuropharm.2012.07.047

Figure 4. R-8-OH-DPAT decreases nNOS mRNA levels, but not CNTF mRNA levels.

Figure 4

A direct microinjection of R-8-OH-DPAT into the area adjacent to the SVZ and SGZ at a dose of 2.75 µg per site per animal. The tissue was collected at 4 hours post injection. A) There were no differences in CNTF mRNA levels in the SVZ or in the HF. B) There was a significant decrease of 25% in the SVZ in nNOS mRNA. There were no changes in the nNOS mRNA levels in the HF. * signifies p<0.05, n= 5 in each group.